Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2023(Status and Outlook)

Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2023(Status and Outlook)



Report Overview

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The Global mRNA Cancer Vaccines and Therapeutics Market Size was estimated at USD 140.40 million in 2022 and is projected to reach USD 474.46 million by 2029, exhibiting a CAGR of 19.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global mRNA Cancer Vaccines and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Cancer Vaccines and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Cancer Vaccines and Therapeutics market in any manner.

Global mRNA Cancer Vaccines and Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Market Segmentation (by Type)

Adeno Carcinomas

Mucinous Carcinomas

Adenosquamous Carcinomas

Market Segmentation (by Application)

General Filtration (Aqueous & Organic)

Sample Preparation

Bead-based Assays

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the mRNA Cancer Vaccines and Therapeutics Market

Overview of the regional outlook of the mRNA Cancer Vaccines and Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of mRNA Cancer Vaccines and Therapeutics
1.2 Key Market Segments
1.2.1 mRNA Cancer Vaccines and Therapeutics Segment by Type
1.2.2 mRNA Cancer Vaccines and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 mRNA Cancer Vaccines and Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global mRNA Cancer Vaccines and Therapeutics Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 mRNA Cancer Vaccines and Therapeutics Market Competitive Landscape
3.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Manufacturers (2018-2023)
3.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Manufacturers (2018-2023)
3.3 mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Cancer Vaccines and Therapeutics Average Price by Manufacturers (2018-2023)
3.5 Manufacturers mRNA Cancer Vaccines and Therapeutics Sales Sites, Area Served, Product Type
3.6 mRNA Cancer Vaccines and Therapeutics Market Competitive Situation and Trends
3.6.1 mRNA Cancer Vaccines and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest mRNA Cancer Vaccines and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
4.1 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of mRNA Cancer Vaccines and Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Type (2018-2023)
6.3 Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2018-2023)
6.4 Global mRNA Cancer Vaccines and Therapeutics Price by Type (2018-2023)
7 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Cancer Vaccines and Therapeutics Market Sales by Application (2018-2023)
7.3 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) by Application (2018-2023)
7.4 Global mRNA Cancer Vaccines and Therapeutics Sales Growth Rate by Application (2018-2023)
8 mRNA Cancer Vaccines and Therapeutics Market Segmentation by Region
8.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Region
8.1.1 Global mRNA Cancer Vaccines and Therapeutics Sales by Region
8.1.2 Global mRNA Cancer Vaccines and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America mRNA Cancer Vaccines and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe mRNA Cancer Vaccines and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific mRNA Cancer Vaccines and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America mRNA Cancer Vaccines and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa mRNA Cancer Vaccines and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Moderna Therapeutics
9.1.1 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
9.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
9.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.1.4 Moderna Therapeutics Business Overview
9.1.5 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics SWOT Analysis
9.1.6 Moderna Therapeutics Recent Developments
9.2 CureVac
9.2.1 CureVac mRNA Cancer Vaccines and Therapeutics Basic Information
9.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Overview
9.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.2.4 CureVac Business Overview
9.2.5 CureVac mRNA Cancer Vaccines and Therapeutics SWOT Analysis
9.2.6 CureVac Recent Developments
9.3 Translate Bio
9.3.1 Translate Bio mRNA Cancer Vaccines and Therapeutics Basic Information
9.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Overview
9.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.3.4 Translate Bio Business Overview
9.3.5 Translate Bio mRNA Cancer Vaccines and Therapeutics SWOT Analysis
9.3.6 Translate Bio Recent Developments
9.4 BioNTech
9.4.1 BioNTech mRNA Cancer Vaccines and Therapeutics Basic Information
9.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Overview
9.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.4.4 BioNTech Business Overview
9.4.5 BioNTech mRNA Cancer Vaccines and Therapeutics SWOT Analysis
9.4.6 BioNTech Recent Developments
9.5 Sangamo Therapeutics
9.5.1 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
9.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
9.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.5.4 Sangamo Therapeutics Business Overview
9.5.5 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics SWOT Analysis
9.5.6 Sangamo Therapeutics Recent Developments
9.6 Argos Therapeutics
9.6.1 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Basic Information
9.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Overview
9.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.6.4 Argos Therapeutics Business Overview
9.6.5 Argos Therapeutics Recent Developments
9.7 In-Cell-Art
9.7.1 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Basic Information
9.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Overview
9.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.7.4 In-Cell-Art Business Overview
9.7.5 In-Cell-Art Recent Developments
9.8 eTheRNA
9.8.1 eTheRNA mRNA Cancer Vaccines and Therapeutics Basic Information
9.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Overview
9.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.8.4 eTheRNA Business Overview
9.8.5 eTheRNA Recent Developments
9.9 Ethris
9.9.1 Ethris mRNA Cancer Vaccines and Therapeutics Basic Information
9.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Overview
9.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.9.4 Ethris Business Overview
9.9.5 Ethris Recent Developments
9.10 Tiba Biotechnology
9.10.1 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Basic Information
9.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Overview
9.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Market Performance
9.10.4 Tiba Biotechnology Business Overview
9.10.5 Tiba Biotechnology Recent Developments
10 mRNA Cancer Vaccines and Therapeutics Market Forecast by Region
10.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast
10.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Region
10.2.4 South America mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of mRNA Cancer Vaccines and Therapeutics by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of mRNA Cancer Vaccines and Therapeutics by Type (2024-2029)
11.1.2 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of mRNA Cancer Vaccines and Therapeutics by Type (2024-2029)
11.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2024-2029)
11.2.1 Global mRNA Cancer Vaccines and Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings